Denmark · Delayed Price · Currency is DKK ALK-Abelló Company Description
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally.
It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma.
The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment.
In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intramuscular injection of adrenaline for the treatment of acute life-threatening allergic reactions including Anaphylaxis.
ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
| Country | Denmark |
| Founded | 1923 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,759 |
| CEO | Peter Halling |
Contact Details
Address: Bøge Allé 6-8 Horsholm Denmark | |
| Phone | 45 45 74 75 76 |
Stock Details
| Ticker Symbol | ALK.B |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | DKK |
| ISIN Number | DK0061802139 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Peter Halling | President, Chief Executive Officer and Member of Management Board |
| Claus Steensen Solje | Executive Vice President, Chief Financial Officer and Member of Management Board |
| Søren Daniel Niegel | Member of Management Board |
| Katja Barnkob Thalund | Senior Project Director, Global Clinical Development and Employee-elected Director |
| Nanna Rassov Carlson | Senior Manager of QA Release and Employee Representative Director |
| Johan Smedsrud | Senior Maintenance Supporter of Process and Production Support & Employee Representative Director |
| Lise Lund Maerkedahl | Project Director of Global Clinical Development and Employee-elected Director |
| Per Plotnikof | Vice President of Corporate Communications, Investor Relations and Strategic Planning and Head of IR |
| Lika Thiesen | Executive Vice President of Global People and Organisation |
| Prof. Hendrik Kees Kam Nolte M.D., Ph.D. | Senior Vice President of Research and Development - North America and International Markets |